NIP
VERA icon

Nicholas Investment Partners’s Vera Therapeutics VERA Stock Holding History

Nicholas Investment Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-95,932
Closed -$3.86M – 238
2026
Q1 		$3.86M Sell
95,932
-48,878
-34% -$2.11M 0.28% 117
2025
Q4 		$7.33M Buy
+144,810
New +$5.14M 0.53% 72
2025
Q2 		– Sell
-95,402
Closed -$2.29M – 230
2025
Q1 		$2.29M Sell
95,402
-11,403
-11% -$366K 0.24% 135
2024
Q4 		$4.52M Buy
106,805
+35,246
+49% +$1.56M 0.4% 97
2024
Q3 		$3.16M Buy
71,559
+12,430
+21% +$472K 0.29% 129
2024
Q2 		$2.14M Buy
+59,129
New +$2.35M 0.22% 141

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nicholas Investment Partners's VERA Position: Q2 2026 in Review

Nicholas Investment Partners sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 95,932 shares — an estimated $3.86M sold.

Nicholas Investment Partners first reported a position in VERA in Q2 2024 and held it in 6 quarters. The position peaked at $7.33M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Nicholas Investment Partners reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Nicholas Investment Partners sold 95,932 Vera Therapeutics shares in Q2 2026, an estimated $3.86M.
  • Nicholas Investment Partners first reported a position in Vera Therapeutics in Q2 2024 and held it in 6 quarters.
  • Nicholas Investment Partners's Vera Therapeutics position peaked at $7.33M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.